Found: 12
Select item for more details and to access through your institution.
PRIORITI: Phase 4 study of triptorelin or active surveillance in high‐risk prostate cancer.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2024, v. 20, n. 6, p. 738, doi. 10.1111/ajco.14101
- By:
- Publication type:
- Article
Triptorelin in the Relief of Lower Urinary Tract Symptoms in Advanced Prostate Cancer Patients: The RESULT Study.
- Published in:
- Prostate Cancer (20903111), 2015, v. 2015, p. 1, doi. 10.1155/2015/978194
- By:
- Publication type:
- Article
Changes in Body Image in Patients with Prostate Cancer over 2 Years of Treatment with a Gonadotropin-Releasing Hormone Analogue (Triptorelin): Results from a Belgian Non-Interventional Study.
- Published in:
- Drugs - Real World Outcomes, 2016, v. 3, n. 2, p. 183, doi. 10.1007/s40801-016-0074-5
- By:
- Publication type:
- Article
Triptorelin for the relief of lower urinary tract symptoms in men with advanced prostate cancer: results of a prospective, observational, grouped-analysis study.
- Published in:
- Therapeutic Advances in Urology, 2017, v. 9, n. 7, p. 179, doi. 10.1177/1756287217712379
- By:
- Publication type:
- Article
A prospective, observational grouped analysis to evaluate the effect of triptorelin on lower urinary tract symptoms in patients with advanced prostate cancer.
- Published in:
- Therapeutic Advances in Urology, 2015, v. 7, n. 3, p. 116, doi. 10.1177/1756287215574480
- By:
- Publication type:
- Article
The pain and daily consequences of living with endometriosis: a qualitative online survey of women in China, France and Russia.
- Published in:
- Journal of Endometriosis & Pelvic Pain Disorders, 2015, v. 7, n. 3, p. 89, doi. 10.5301/je.5000222
- By:
- Publication type:
- Article
Factors predicting progression to castrate-resistant prostate cancer in patients with advanced prostate cancer receiving long-term androgen-deprivation therapy.
- Published in:
- BJU International, 2017, v. 119, n. 1, p. 74, doi. 10.1111/bju.13455
- By:
- Publication type:
- Article
Evaluation of urinary prostate cancer antigen-3 ( PCA3) and TMPRSS2- ERG score changes when starting androgen-deprivation therapy with triptorelin 6-month formulation in patients with locally advanced and metastatic prostate cancer.
- Published in:
- BJU International, 2014, v. 114, n. 4, p. 608, doi. 10.1111/bju.12542
- By:
- Publication type:
- Article
Efficacy and Safety of Triptorelin 3-Month Formulation in Chinese Children with Central Precocious Puberty: A Phase 3, Open-Label, Single-Arm Study.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 10, p. 4574, doi. 10.1007/s12325-023-02617-8
- By:
- Publication type:
- Article
Assessment of Two Formulations of Triptorelin in Chinese Patients with Endometriosis: A Phase 3, Randomized Controlled Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Efficacy of Testosterone Suppression with Sustained-Release Triptorelin in Advanced Prostate Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Factors and Regional Differences Associated with Endometriosis: A Multi-Country, Case-Control Study.
- Published in:
- 2016
- By:
- Publication type:
- journal article